Revolutionizing disease risk prediction with AI
Geno10X Biosciences Ltd is a Canadian AI-enabled medical device startup building a rapid disease detection platform. Our mission is to bring to market an intelligent, non-invasive, rapid and accurate testing platform that is accessible to everyone.
01.
Patient First Platform
Our AI-enabled digital health platform is designed from the ground-up to identify those in most need of advanced care, easing the care journey for both patients and providers. We use rapid tests using samples collected non-invasively, paired with best-in-class AI algorithms to predict risk of developing disease. Our decentralised Point of Care Testing (POCT) stations make sample processing and readouts fast and easy to interpret, reducing the burden on the healthcare system.
02.
Tomorrow's Technology Today
We use proprietary dyes, quantum dots, and next generation imaging sensors developed in Canada. Our technology is tuned to achieve high sensitivity and specificity to detect molecular biomarkers in urine samples without requiring PCR. Paired with our custom-built AI algorithms, our novel tests can accurately predict risk of developing disease, enabling timely intervention by physicians. All at a fraction of the cost and time taken by traditional testing.
03.
How We Engage
We work with local and provincial governments, healthcare clinics, diagnostic labs, hospitals, and software developers experienced in using AI for health data. We collaborate with top Canadian research labs to license and develop technologies focused on rapid and sensitive DNA and protein detection. We have partnered with Gene Bio Medical, a top Canadian molecular diagnostics leader to leverage their distribution channels and sales networks.
04.
Contact Us
Get in touch to know more about the company, team, careers and partnering. We are actively seeking investment to build our team in Vancouver, British Columbia and launch our testing platform.
© 2024. All rights reserved.